No Data
Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645.SH): A holding subsidiary has signed a Property Service entrustment contract.
On January 8, Gelonghui reported that Vcanbio Cell & Gene Engineering Corp.,Ltd. (stock code 600645.SH) announced that due to operational needs and through friendly negotiation, Concord Stem Cell Gene Engineering Co., Ltd. (referred to as "Concord Stem Cell") plans to continue entrusting Tianjin Hongkan Property Management Co., Ltd. (referred to as "Hongkan Property") to manage the property services in the Huayuan Industrial Park located at No. 12 Meiyuan Road, Tianjin. The services will include cleaning, order maintenance, landscaping, special rental arrangements, special laundry bottle washing, and dining services, with an annual service fee of 6,379,451.28 yuan, and a total contract service fee of 19,138,353.84 yuan.
Vcanbio Cell & Gene Engineering (SHSE:600645) Lifts 5.0% This Week, Taking Five-year Gains to 29%
Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645.SH): VUM02 injection for the treatment of acute graft-versus-host disease has received orphan drug designation from the FDA in the USA.
Vcanbio Cell & Gene Engineering Corp.,Ltd. (600645.SH) announced that its wholly-owned subsidiary Wuhan Guanggu Vcanbio Pharmaceutical Co., Ltd. ("Wuhan...
Vcanbio Cell & Gene Engineering (SHSE:600645) Seems To Use Debt Quite Sensibly
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. Report for the third quarter of 2024
vcanbio cell & gene engineering corp.,ltd. (600645.SH) released its performance for the first three quarters, with a net income of 0.134 billion yuan, a year-on-year increase of 0.76%.
vcanbio cell & gene engineering corp.,ltd. (600645.SH) disclosed its third quarter report for 2024, achieving operating income in the first three quarters...
The Five-year Loss for Vcanbio Cell & Gene Engineering (SHSE:600645) Shareholders Likely Driven by Its Shrinking Earnings
No Data
